Ticker Details
Neuronetics, Inc. Common Stock
IPO Date:	June 25, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$228.59M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 4.44%
Avg Daily Range (30 D):	$0.14 | 6.63%
Avg Daily Range (90 D):	$0.10 | 5.74%

Institutional Daily Volume
Avg Daily Volume:	.54M
Avg Daily Volume (30 D):	2.82M
Avg Daily Volume (90 D):	2.22M

Trade Size
Avg Trade Size (Sh.):	181
Avg Trade Size (Sh.) (30 D):	180
Avg Trade Size (Sh.) (90 D):	239

Institutional Trades
Total Institutional Trades:	157
Avg Institutional Trade:	$1.9M
Avg Institutional Trade (30 D):	$4.95M
Avg Institutional Trade (90 D):	$2.82M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.36M
Avg Closing Trade (30 D):	$4.95M
Avg Closing Trade (90 D):	$2.82M
Avg Closing Volume:	609.92K

News

Apr 10, 2026 @ 6:27 PM Deal Dispatch: Unilever Buys Grüns, Pershing Sq... Source: Caroline Ryan

Oct 31, 2025 @ 8:30 PM Neuronetics Reports Inducement Grant Under Nasdaq ... Source: Neuronetics, Inc.

Dec 10, 2024 @ 3:00 PM Neuronetics and Greenbrook TMS Announce Closing of... Source: N/A

Jul 2, 2024 @ 2:40 PM Neuronetics (STIM) Expands NeuroStar Portfolio Wit... Source: Zacks Equity Research

Jul 1, 2024 @ 12:02 PM NeuroStar® Launches Better Me Provider Program ... Source: Neuronetics

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.05	$-.16
Diluted EPS		$-.05	$-.16
Revenue		$41.57M	$34.45M
Gross Profit		$21.22M	$16.15M
Net Income / Loss		$-3.46M	$-10.78M
Operating Income / Loss		$-1.5M	$-9M
Cost of Revenue		$20.35M	$18.3M
Net Cash Flow	$-27.6M	$5.98M	$-15.17M
PE Ratio